Coronavirus 2019

The Coronavirus Pandemic and the Future

Ivermectin Meta-analysis of COVID-19

Ivermectin for COVID-19: real-time meta analysis of 55 studies (ivmmeta.com)

Ivermectin for COVID-19: real-time analysis of all 93 studies (c19ivermectin.com)

HCQ for COVID-19: real-time analysis of all 293 studies (c19hcq.com)

Sleep, Immune System and COVID-19

Coronavirus resource center at the Johns Hopkins University

Washington Post

Global nCov2019 Live Data

NIH COVID-19 Open Access Data Resources

Hydroxychloroquine trials and studies

SARS-Coronavirus-2 Information/

LitCovid

Research on COVID-19 in the Environment

Cleaning and Disinfection for Households

Up to date scientific publications about the 2019 novel Coronavirus.

Preprint

Chloroquine for the 2019 novel coronavirus SARS-CoV-2. A brief review on chloroquine, a drug that has been used for treatment of malaria, and hydroxychloroquine, a drug that have been used to treat autoimmune diseases such as systemic lupus erythematosus (SLE), a multisystem autoimmune disease that affects various organs.

Centers for Disease Control and Prevention

China CDC Weekly

New England Journal of Medicine, JAMA, Lancet, BMJ

Nature, CELL

G6PD Levels Before Prescribing HCQ

Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso

Examination of Hydroxychloroquine Use and Hemolytic Anemia in G6PDH-Deficient Patients.

The treatment of malaria in glucose-6-phosphate dehydrogenase deficient patients in Sabah.

Hemolysis with anti-malarial drugs in glucose 6 phosphate dehydrogenase deficiency.